These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

447 related articles for article (PubMed ID: 34078221)

  • 1. Liver resection versus radiofrequency ablation for recurrent hepatocellular carcinoma: a systematic review and meta-analysis.
    Yang Y; Yu H; Tan X; You Y; Liu F; Zhao T; Qi J; Li J; Feng Y; Zhu Q
    Int J Hyperthermia; 2021; 38(1):875-886. PubMed ID: 34078221
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of liver resection and radiofrequency ablation in long-term survival among patients with early-stage hepatocellular carcinoma: a meta-analysis of randomized trials and high-quality propensity score-matched studies.
    Hu L; Lin J; Wang A; Shi X; Qiao Y
    World J Surg Oncol; 2024 Feb; 22(1):56. PubMed ID: 38369480
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Radiofrequency ablation versus repeat resection for recurrent hepatocellular carcinoma (≤ 5 cm) after initial curative resection.
    Feng Y; Wu H; Huang DQ; Xu C; Zheng H; Maeda M; Zhao X; Wang L; Xiao F; Lv H; Liu T; Qi J; Li J; Zhong N; Wang C; Feng H; Liang B; Ren W; Qin C; Nguyen MH; Zhu Q
    Eur Radiol; 2020 Nov; 30(11):6357-6368. PubMed ID: 32529568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of microwave ablation and radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Tan W; Deng Q; Lin S; Wang Y; Xu G
    Int J Hyperthermia; 2019; 36(1):264-272. PubMed ID: 30676100
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical outcomes of surgical resection versus radiofrequency ablation in very-early-stage hepatocellular carcinoma: a propensity score matching analysis.
    Li YC; Chen PH; Yeh JH; Hsiao P; Lo GH; Tan T; Cheng PN; Lin HY; Chen YS; Hsieh KC; Hsieh PM; Lin CW
    BMC Gastroenterol; 2021 Nov; 21(1):418. PubMed ID: 34749663
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The risk factors for long-term survival outcome in solitary hepatocellular carcinoma up to 2 cm: Propensity score matching analysis in a population cohort with a high rate of HBV infection.
    Wang G; Zhang W; Tan Y; Jiang L; Yang J; Yang J; Yan L
    Int J Surg; 2019 Dec; 72():1-6. PubMed ID: 31610283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiofrequency ablation versus hepatic resection for recurrent hepatocellular carcinoma: an updated meta-analysis.
    Yang D; Zhuang B; Wang Y; Xie X; Xie X
    BMC Gastroenterol; 2020 Nov; 20(1):402. PubMed ID: 33246417
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LI-RADS category is associated with treatment outcomes of small single HCC: surgical resection vs. radiofrequency ablation.
    Min JH; Lee MW; Rhim H; Han S; Song KD; Kang TW; Jeong WK; Cha DI; Kim JM; Choi GS; Kim K
    Eur Radiol; 2024 Jan; 34(1):525-537. PubMed ID: 37526668
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The 10-year Survival Analysis of Radiofrequency Ablation for Solitary Hepatocellular Carcinoma 5 cm or Smaller: Primary versus Recurrent HCC.
    Bai XM; Cui M; Yang W; Wang H; Wang S; Zhang ZY; Wu W; Chen MH; Yan K; Goldberg SN
    Radiology; 2021 Aug; 300(2):458-469. PubMed ID: 34003058
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overall survival and local recurrence following RFA, MWA, and cryoablation of very early and early HCC: a systematic review and Bayesian network meta-analysis.
    Gupta P; Maralakunte M; Kumar-M P; Chandel K; Chaluvashetty SB; Bhujade H; Kalra N; Sandhu MS
    Eur Radiol; 2021 Jul; 31(7):5400-5408. PubMed ID: 33439319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Minimally invasive surgery versus radiofrequency ablation for single subcapsular hepatocellular carcinoma ≤ 2 cm with compensated liver cirrhosis.
    Lin CH; Ho CM; Wu CH; Liang PC; Wu YM; Hu RH; Lee PH; Ho MC
    Surg Endosc; 2020 Dec; 34(12):5566-5573. PubMed ID: 31993821
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Liver Resection Versus Local Ablation Therapies for Hepatocellular Carcinoma Within the Milan Criteria: A Systematic Review and Meta-analysis.
    Shin SW; Ahn KS; Kim SW; Kim TS; Kim YH; Kang KJ
    Ann Surg; 2021 Apr; 273(4):656-666. PubMed ID: 33074898
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Laparoscopic liver resection is superior to radiofrequency ablation for small hepatocellular carcinoma: a systematic review and meta-analysis of propensity score-matched studies.
    Chen W; Lin X; Wu Z; Pan W; Ke Q; Chen Y
    Hepatol Int; 2024 Jun; 18(3):998-1010. PubMed ID: 38480604
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Trans-arterial chemoembolization + radiofrequency ablation versus surgical resection in hepatocellular carcinoma - A meta-analysis.
    Gui CH; Baey S; D'cruz RT; Shelat VG
    Eur J Surg Oncol; 2020 May; 46(5):763-771. PubMed ID: 31937433
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The (Eternal) Debate on Microwave Ablation
    Ricci AD; Rizzo A; Bonucci C; Tavolari S; Palloni A; Frega G; Mollica V; Tober N; Mazzotta E; Felicani C; Serra C; Brandi G
    In Vivo; 2020; 34(6):3421-3429. PubMed ID: 33144450
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Combined transcatheter arterial chemoembolization and radiofrequency ablation versus hepatectomy for recurrent hepatocellular carcinoma after initial surgery: a propensity score matching study.
    Peng Z; Wei M; Chen S; Lin M; Jiang C; Mei J; Li B; Wang Y; Li J; Xie X; Kuang M
    Eur Radiol; 2018 Aug; 28(8):3522-3531. PubMed ID: 29536241
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radiofrequency ablation
    Conticchio M; Inchingolo R; Delvecchio A; Laera L; Ratti F; Gelli M; Anelli F; Laurent A; Vitali G; Magistri P; Assirati G; Felli E; Wakabayashi T; Pessaux P; Piardi T; di Benedetto F; de'Angelis N; Briceño J; Rampoldi A; Adam R; Cherqui D; Aldrighetti LA; Memeo R
    World J Gastroenterol; 2021 May; 27(18):2205-2218. PubMed ID: 34025074
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of radiofrequency ablation for initial recurrent hepatocellular carcinoma after curative treatment: Comparison with primary cases.
    Fukuhara T; Aikata H; Hyogo H; Honda Y; Morio K; Morio R; Hatooka M; Kobayashi T; Naeshiro N; Kawaoka T; Tsuge M; Hiramatsu A; Imamura M; Kawakami Y; Chayama K
    Eur J Radiol; 2015 Aug; 84(8):1540-1545. PubMed ID: 25979193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Stereotactic body radiotherapy versus radiofrequency ablation for hepatocellular carcinoma: a systematic review and meta-analysis.
    Wang L; Ke Q; Huang Q; Shao L; Chen J; Wu J
    Int J Hyperthermia; 2020; 37(1):1313-1321. PubMed ID: 33243024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Individual or combined transcatheter arterial chemoembolization and radiofrequency ablation for hepatocellular carcinoma: a time-to-event meta-analysis.
    Jiang C; Cheng G; Liao M; Huang J
    World J Surg Oncol; 2021 Mar; 19(1):81. PubMed ID: 33741001
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.